Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Mark Hatfield, PhD, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Ahuva Hanau, BS, Alex Lonshteyn, PhD, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 4668.

https://doi.org/10.1182/blood-2019-123999

Published: 2019

Journal Articles

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

Hanne Rozema, MSc, Robby Kibbelaar, Dr., Nic Veeger, Dr., Mels Hoogendoorn, Dr., Eric van Roon, Prof. Dr.

Blood (2019) 134 (Supplement_1): 4253.

https://doi.org/10.1182/blood-2019-123357

Published: 2019

Journal Articles

Blood group genotyping

Connie M. Westhoff

Blood (2019) 133 (17): 1814–1820.

https://doi.org/10.1182/blood-2018-11-833954

Published: 2019

Journal Articles

Ticagrelor Induced Platelet Dysfunction Can be Assessed Under Shear Conditions and Correction By Platelets Is Influenced By Storage Temperature

Thomas Scorer, MBBS,FRCPath,BSc,MRCP, Umang Sharma, BS, Grantham Peltier, MS, Colby McIntosh, BS, Kristin M Reddoch-Cardenas, PhD, Andrew David Mumford, Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 526.

https://doi.org/10.1182/blood-2018-99-111428

Published: 2018

Journal Articles

Accurate Prediction of RH Genotypes Using Whole Genome Sequencing Data

Yan Zheng, MD PhD, Ti-Cheng Chang, PhD, Gang Wu, PhD, Jane S. Hankins, MD MS, Mitchell J. Weiss, MD PhD, Connie M. Westhoff, PhD, Stella T. Chou, MD

Blood (2018) 132 (Supplement 1): 2332.

https://doi.org/10.1182/blood-2018-99-119681

Published: 2018

Journal Articles

RH genotype matching for transfusion support in sickle cell disease

Stella T. Chou, Perry Evans, Sunitha Vege, Sarita L. Coleman, David F. Friedman, Margaret Keller, Connie M. Westhoff

Blood (2018) 132 (11): 1198–1207.

https://doi.org/10.1182/blood-2018-05-851360

Published: 2018

Includes: Supplemental data

Journal Articles

Antibody-Mediated Immunosuppression Can Result from RBC Antigen Loss Independent of Fcγ Receptors in Mice

Amanda Mener, Seema R Patel, BS, PhD, Connie Arthur, PhD, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 2403.

https://doi.org/10.1182/blood.V130.Suppl_1.2403.2403

Published: 2017

Journal Articles

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

David Posocco, Hyun H An, Jean Ann Maguire, Judith Aeschlimann, Deborah L French, PhD, Paul Gadue, PhD, Connie M. Westhoff, PhD, Stella T Chou, MD

Blood (2017) 130 (Supplement 1): 3.

https://doi.org/10.1182/blood.V130.Suppl_1.3.3

Published: 2017

Journal Articles

Difficulties in Managing a Sickle Cell Patient with a Variant C Antigen and Multiple Alloantibodies Including Anti-Dombrock a

Jung Moon, MD MMSc, Eugenia Bryan, MD

Blood (2017) 130 (Supplement 1): 4933.

https://doi.org/10.1182/blood.V130.Suppl_1.4933.4933

Published: 2017

Journal Articles

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

Lai Heng Lee, MBBS,FRCP, Ming Chai Kong, Isabelle Teo, Shun Wei Lim, Jin Shing Hon, Kelly Bee Ling Chng, Sing Lin Tee, Elicia Purnata, Clifton You Xuan Liew, Xin Hui Loh, Cui Mei Fong, Nirmali Ruth Sivapragasam, Yiong Huak Chan, Jiang Ming Fam, Heng Joo Ng, Marcus Eng Hock Ong, David Bruce Matchar

Blood (2017) 130 (Supplement 1): 3719.

https://doi.org/10.1182/blood.V130.Suppl_1.3719.3719

Published: 2017

Journal Articles

B-RhD-Positive Blood Group Appears Relatively Less Susceptible to Anemia in Sickle Cell Disease Pregnant Women

Ogbonna Collins Nwabuko, MBBS, FMCPath, Dorathy Adaunwa Okoh, MB,ChB; FMCPath, FWACP, Christian Aluka, MBBS, MRCOG, FWACS, FICS, FRCOG

Blood (2017) 130 (Supplement 1): 4796.

https://doi.org/10.1182/blood.V130.Suppl_1.4796.4796

Published: 2017

Journal Articles

IgG Subtype Affects Immunomodulation through FcγRs, on Non-Macrophage Populations in a Murine Model - Mechanistic Implications for Anti-D

James C. Zimring, MD PhD, Hayley Waterman, Xiaohong Wang, PhD, Linda Kapp, Jenna Lebedev, Heather Howie, PhD, Ariel Hay, Tamara Carola Stegmann, MSc, Gestur Vidarsson, PhD, C. Ellen Van der Schoot, MD PhD Prof.

Blood (2016) 128 (22): 21.

https://doi.org/10.1182/blood.V128.22.21.21

Published: 2016

Journal Articles

The Immunogenicity of Red Blood Cell Antigens in Relation to Antigen Exposure

Dorothea Evers, MD, Rutger Middelburg, PhD, Masja De Haas, Prof, MD, Saurabh Zalpuri, MD PhD, Karen de Vooght, PhD, Daan van de Kerkhof, PhD, Otto Visser, MD PhD, Nathalie Pequeriaux, Francisca Hudig, PhD, Henk Schonewille, PhD, Jaap Jan Zwaginga, MD PhD, Anske van der Bom, MD PhD

Blood (2015) 126 (23): 1139.

https://doi.org/10.1182/blood.V126.23.1139.1139

Published: 2015

Journal Articles

Neutrophils Contribute to RBC Alloantibody Production

Amanda L Richards, James C. Zimring, MD PhD, Krystalyn E. Hudson, PhD

Blood (2015) 126 (23): 3437.

https://doi.org/10.1182/blood.V126.23.3437.3437

Published: 2015

Journal Articles

Anti-RhD Mediates Loss of RhD Antigen Following Anti-RhD Infusion

Harold Clifford Sullivan, MD, Connie Maridith Arthur, PhD, Seema Patel, PhD, Jeanne E. Hendrickson, MD, Alan H Lazarus, PhD, Sean R. Stowell, MD PhD

Blood (2015) 126 (23): 3570.

https://doi.org/10.1182/blood.V126.23.3570.3570

Published: 2015

Journal Articles

Designated Donor Program Enrollment Does Not Affect Red Blood Cell Alloimmunization Rates in Children with Sickle Cell Disease on Chronic Transfusion Therapy

Ronald Jackups, MD PhD, Debbie Woods, RN, MSN, CPNP, Robert J. Hayashi, MD, Monica L. Hulbert, MD

Blood (2014) 124 (21): 4291.

https://doi.org/10.1182/blood.V124.21.4291.4291

Published: 2014

Journal Articles

Feasibility of RH Genetic Matching for Patients with Sickle Cell Disease with an African-American Donor Pool

Stella T. Chou, MD, David F. Friedman, MD, Tannoa Jackson, BS, Sunitha Vege, Margaret A. Keller, PhD, Connie M Westhoff, PhD

Blood (2014) 124 (21): 2893.

https://doi.org/10.1182/blood.V124.21.2893.2893

Published: 2014

Journal Articles

Long-Term Follow-up of Survival, Complications, Arsenic Retention and Quality of Life in Patients with Newly Diagnosed Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid/Arsenic Trioxide Combination Therapy

Hongming Zhu, Jiong Hu, Li Chen, Wei Zhou, Xiaoyang Li, Wang Lining, Xia Zhao, Yunxiang Zhang, Huijin Zhao, Yu Chen, Huiping Sun, Qiusheng Chen, Yu Chen, Weili Zhao, Jianqing Mi, Zhixiang Shen, Saijuan Chen, Zhenyi Wang, Junmin Li, MD PhD

Blood (2014) 124 (21): 282.

https://doi.org/10.1182/blood.V124.21.282.282

Published: 2014

Journal Articles

Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine Model

Sean R. Stowell, MD PhD, Connie M Arthur, PhD, Kathryn R. Girard-Pierce, PhD, Harold Clifford Sullivan, MD, Manjula Santhanakrishnan, Prabitha Natarajan, PhD, Christopher A. Tormey, MD, James C. Zimring, MD PhD, Jeanne E Hendrickson, MD

Blood (2014) 124 (21): 758.

https://doi.org/10.1182/blood.V124.21.758.758

Published: 2014

Journal Articles

RhD Immunization Despite Adequate Immunoprophylaxis: Role of Fc Gamma Receptor Gene Polymorphisms

Tamara C Stegmann, Sietse Q Nagelkerke, MD, Dian van Winkelhorst, MD, Taco W Kuijpers, MD PhD, Gestur Vidarsson, PhD, C. Ellen van der Schoot, MD PhD

Blood (2014) 124 (21): 759.

https://doi.org/10.1182/blood.V124.21.759.759

Published: 2014

NARROW

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

Blood group genotyping

Ticagrelor Induced Platelet Dysfunction Can be Assessed Under Shear Conditions and Correction By Platelets Is Influenced By Storage Temperature

Accurate Prediction of RH Genotypes Using Whole Genome Sequencing Data

RH genotype matching for transfusion support in sickle cell disease

Antibody-Mediated Immunosuppression Can Result from RBC Antigen Loss Independent of Fcγ Receptors in Mice

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

Difficulties in Managing a Sickle Cell Patient with a Variant C Antigen and Multiple Alloantibodies Including Anti-Dombrock a

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

B-RhD-Positive Blood Group Appears Relatively Less Susceptible to Anemia in Sickle Cell Disease Pregnant Women

IgG Subtype Affects Immunomodulation through FcγRs, on Non-Macrophage Populations in a Murine Model - Mechanistic Implications for Anti-D

The Immunogenicity of Red Blood Cell Antigens in Relation to Antigen Exposure

Neutrophils Contribute to RBC Alloantibody Production

Anti-RhD Mediates Loss of RhD Antigen Following Anti-RhD Infusion

Designated Donor Program Enrollment Does Not Affect Red Blood Cell Alloimmunization Rates in Children with Sickle Cell Disease on Chronic Transfusion Therapy

Feasibility of RH Genetic Matching for Patients with Sickle Cell Disease with an African-American Donor Pool

Long-Term Follow-up of Survival, Complications, Arsenic Retention and Quality of Life in Patients with Newly Diagnosed Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid/Arsenic Trioxide Combination Therapy

Polyclonal Anti-Kel (KELGAM) Prevents Alloimmunization to Transfused Kel RBCs in a Murine Model

RhD Immunization Despite Adequate Immunoprophylaxis: Role of Fc Gamma Receptor Gene Polymorphisms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only